GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Windlas Biotech Ltd

Windlas Biotech: Ashok Kumar Windlass Appointed Founder President

MANAGEMENT ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 05 Nov 2026, 05:25 PM IST  ·  BSE ID: 94bac9f9-8209-4916-836a-7a8d3b6f4f99
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's founder is taking on a new senior management role after stepping down as a director.
🤖 AI Summary
  • Mr. Ashok Kumar Windlass appointed Founder President, effective November 6, 2026.
  • Appointment follows Mr. Windlass's resignation as Whole-time Director on November 5, 2026.
  • Board approved financial results for the quarter and half year ended September 30, 2026.
  • Mr. Windlass's move is part of the company's long-term succession planning.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Quarter ended September 30, 2026
Unaudited Financial Results
Half year ended September 30, 2026
Unaudited Financial Results
🏢 How This Affects the Company
📈
Business Impact
This appointment signifies a continued role for a key founder within senior management, potentially aiding strategic direction. The transition from Whole-time Director to Founder President suggests a shift in operational responsibilities.
💰
Financial Impact
The filing does not contain specific financial figures directly related to this management change. The reported financial results for Q2 FY27 and H1 FY27 are separate from the management appointment event.
⚙️
Operational Impact
The company is implementing succession planning with Mr. Windlass shifting his role. This may lead to adjustments in management structure and decision-making processes.
⚠️
Risk Impact
The transition appears to be a structured succession, mitigating immediate governance risks. However, long-term execution of the succession plan will be a factor.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders regarding this management change or financial results.
👤
Who Is Affected
All shareholders are informed of the management transition and the company's latest financial performance for Q2 FY27 and H1 FY27.
🔍
Management Signal
The appointment of Mr. Windlass as Founder President signals a continued involvement of the founder in a strategic capacity post-directorship.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Subsequent board meetings for operational updates.
Future financial results announcements for performance trends.
Management commentary on the succession plan's impact.
LOW RISK Management change is part of structured succession planning, with no immediate financial risk flagged.
💡 Investor Takeaway
Windlas Biotech appointed Mr. Ashok Kumar Windlass as Founder President, effective November 6, 2026, as part of succession planning. The company also approved Q2 FY27 and H1 FY27 financial results.
📅 Company Track Record
Mr. Ashok Kumar Windlass previously resigned as Whole-time Director and Director on November 5, 2026. Earlier, independent director Mr. Vivek Dhariwal resigned on October 13, 2026.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
Who has been appointed as Founder President at Windlas Biotech?
Mr. Ashok Kumar Windlass has been appointed as Founder President (Senior Management Personnel) of Windlas Biotech, effective November 6, 2026.
What is the effective date for Mr. Ashok Kumar Windlass's new role?
The appointment of Mr. Ashok Kumar Windlass as Founder President is effective from November 6, 2026.
Why did Mr. Ashok Kumar Windlass step down as Whole-time Director?
Mr. Ashok Kumar Windlass resigned as Whole-time Director due to the company's long-term succession planning.
What financial results did Windlas Biotech approve?
Windlas Biotech approved the Unaudited Financial Results for the quarter and half year ended September 30, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.